Logo image of 8TI.DE

STELLANTIS NV (8TI.DE) Stock Fundamental Analysis

Europe - FRA:8TI - NL00150001Q9 - Common Stock

8.711 EUR
-0.09 (-1.02%)
Last: 11/6/2025, 7:00:00 PM
Fundamental Rating

2

8TI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 30 industry peers in the Automobiles industry. 8TI has a bad profitability rating. Also its financial health evaluation is rather negative. 8TI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year 8TI has reported negative net income.
8TI had a negative operating cash flow in the past year.
8TI had positive earnings in each of the past 5 years.
In the past 5 years 8TI always reported a positive cash flow from operatings.
8TI.DE Yearly Net Income VS EBIT VS OCF VS FCF8TI.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

1.2 Ratios

8TI has a Return On Assets of -1.19%. This is in the lower half of the industry: 8TI underperforms 60.00% of its industry peers.
Looking at the Return On Equity, with a value of -3.27%, 8TI is doing worse than 60.00% of the companies in the same industry.
Industry RankSector Rank
ROA -1.19%
ROE -3.27%
ROIC N/A
ROA(3y)6.95%
ROA(5y)5.83%
ROE(3y)17.6%
ROE(5y)15.66%
ROIC(3y)N/A
ROIC(5y)N/A
8TI.DE Yearly ROA, ROE, ROIC8TI.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

8TI's Profit Margin has declined in the last couple of years.
8TI's Operating Margin has declined in the last couple of years.
8TI has a worse Gross Margin (7.74%) than 76.67% of its industry peers.
In the last couple of years the Gross Margin of 8TI has remained more or less at the same level.
8TI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.74%
OM growth 3Y-28.95%
OM growth 5Y-7.06%
PM growth 3Y-28.4%
PM growth 5Y-10.63%
GM growth 3Y-13.66%
GM growth 5Y-1.49%
8TI.DE Yearly Profit, Operating, Gross Margins8TI.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

2

2. Health

2.1 Basic Checks

8TI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, 8TI has less shares outstanding
The number of shares outstanding for 8TI has been increased compared to 5 years ago.
Compared to 1 year ago, 8TI has a worse debt to assets ratio.
8TI.DE Yearly Shares Outstanding8TI.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
8TI.DE Yearly Total Debt VS Total Assets8TI.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

2.2 Solvency

8TI has an Altman-Z score of 1.34. This is a bad value and indicates that 8TI is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of 8TI (1.34) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.38 indicates that 8TI is not too dependend on debt financing.
8TI's Debt to Equity ratio of 0.38 is fine compared to the rest of the industry. 8TI outperforms 73.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 1.34
ROIC/WACCN/A
WACC6.92%
8TI.DE Yearly LT Debt VS Equity VS FCF8TI.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B

2.3 Liquidity

8TI has a Current Ratio of 1.06. This is a normal value and indicates that 8TI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.06, 8TI is doing worse than 63.33% of the companies in the same industry.
A Quick Ratio of 0.77 indicates that 8TI may have some problems paying its short term obligations.
With a Quick ratio value of 0.77, 8TI is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.77
8TI.DE Yearly Current Assets VS Current Liabilites8TI.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

3

3. Growth

3.1 Past

8TI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -118.93%.
The earnings per share for 8TI have been decreasing by -15.26% on average. This is quite bad
Looking at the last year, 8TI shows a very negative growth in Revenue. The Revenue has decreased by -17.07% in the last year.
Measured over the past years, 8TI shows a small growth in Revenue. The Revenue has been growing by 7.72% on average per year.
EPS 1Y (TTM)-118.93%
EPS 3Y-25.78%
EPS 5Y-15.26%
EPS Q2Q%-141.95%
Revenue 1Y (TTM)-17.07%
Revenue growth 3Y1.64%
Revenue growth 5Y7.72%
Sales Q2Q%71.49%

3.2 Future

The Earnings Per Share is expected to grow by 7.96% on average over the next years.
Based on estimates for the next years, 8TI will show a small growth in Revenue. The Revenue will grow by 3.49% on average per year.
EPS Next Y-83%
EPS Next 2Y-16.54%
EPS Next 3Y-1.94%
EPS Next 5Y7.96%
Revenue Next Year-2.79%
Revenue Next 2Y1.13%
Revenue Next 3Y1.93%
Revenue Next 5Y3.49%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
8TI.DE Yearly Revenue VS Estimates8TI.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50B 100B 150B 200B
8TI.DE Yearly EPS VS Estimates8TI.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

8TI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 5.50 indicates a rather cheap valuation of 8TI.
Based on the Price/Forward Earnings ratio, 8TI is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 31.86. 8TI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 5.5
8TI.DE Price Earnings VS Forward Price Earnings8TI.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

63.33% of the companies in the same industry are more expensive than 8TI, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.72
8TI.DE Per share data8TI.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.54%
EPS Next 3Y-1.94%

0

5. Dividend

5.1 Amount

No dividends for 8TI!.
Industry RankSector Rank
Dividend Yield N/A

STELLANTIS NV

FRA:8TI (11/6/2025, 7:00:00 PM)

8.711

-0.09 (-1.02%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)02-24 2026-02-24/amc
Inst Owners50.06%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap25.23B
Revenue(TTM)146.12B
Net Income(TTM)-2.39B
Analysts68
Price Target9.39 (7.79%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend1.58
Dividend Growth(5Y)0.29%
DP-81.93%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.08%
PT rev (3m)-11.74%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-81.29%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.5
P/S 0.17
P/FCF N/A
P/OCF N/A
P/B 0.35
P/tB 1.08
EV/EBITDA 6.72
EPS(TTM)-0.83
EYN/A
EPS(NY)1.58
Fwd EY18.2%
FCF(TTM)-4.68
FCFYN/A
OCF(TTM)-1.05
OCFYN/A
SpS50.46
BVpS25.25
TBVpS8.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.19%
ROE -3.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.74%
FCFM N/A
ROA(3y)6.95%
ROA(5y)5.83%
ROE(3y)17.6%
ROE(5y)15.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)13.77%
ROCE(5y)12.77%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-28.95%
OM growth 5Y-7.06%
PM growth 3Y-28.4%
PM growth 5Y-10.63%
GM growth 3Y-13.66%
GM growth 5Y-1.49%
F-Score1
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA 5.91
Cap/Depr 145.84%
Cap/Sales 7.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.77
Altman-Z 1.34
F-Score1
WACC6.92%
ROIC/WACCN/A
Cap/Depr(3y)140.23%
Cap/Depr(5y)152.03%
Cap/Sales(3y)5.82%
Cap/Sales(5y)6.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-118.93%
EPS 3Y-25.78%
EPS 5Y-15.26%
EPS Q2Q%-141.95%
EPS Next Y-83%
EPS Next 2Y-16.54%
EPS Next 3Y-1.94%
EPS Next 5Y7.96%
Revenue 1Y (TTM)-17.07%
Revenue growth 3Y1.64%
Revenue growth 5Y7.72%
Sales Q2Q%71.49%
Revenue Next Year-2.79%
Revenue Next 2Y1.13%
Revenue Next 3Y1.93%
Revenue Next 5Y3.49%
EBIT growth 1Y-114.76%
EBIT growth 3Y-27.78%
EBIT growth 5Y0.11%
EBIT Next Year17.69%
EBIT Next 3Y26.55%
EBIT Next 5Y21.37%
FCF growth 1Y-193.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-112.94%
OCF growth 3Y-40.45%
OCF growth 5Y-18.8%

STELLANTIS NV / 8TI.DE FAQ

Can you provide the ChartMill fundamental rating for STELLANTIS NV?

ChartMill assigns a fundamental rating of 2 / 10 to 8TI.DE.


Can you provide the valuation status for STELLANTIS NV?

ChartMill assigns a valuation rating of 3 / 10 to STELLANTIS NV (8TI.DE). This can be considered as Overvalued.


How profitable is STELLANTIS NV (8TI.DE) stock?

STELLANTIS NV (8TI.DE) has a profitability rating of 2 / 10.


How financially healthy is STELLANTIS NV?

The financial health rating of STELLANTIS NV (8TI.DE) is 2 / 10.


Is the dividend of STELLANTIS NV sustainable?

The dividend rating of STELLANTIS NV (8TI.DE) is 0 / 10 and the dividend payout ratio is -81.93%.